153 related articles for article (PubMed ID: 31280618)
41. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.
Rommel FM; Agusta VE; Breslin JA; Huffnagle HW; Pohl CE; Sieber PR; Stahl CA
J Urol; 1994 Jan; 151(1):88-93. PubMed ID: 7504748
[TBL] [Abstract][Full Text] [Related]
42. The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level ≤ 15 ng/ml and normal digital rectal examination: a 10-year prospective follow-up study of 427 consecutive patients.
Mohamed ZK; Dominguez-Escrig J; Vasdev N; Bharathan B; Greene D
Urol Oncol; 2013 Nov; 31(8):1489-96. PubMed ID: 22591749
[TBL] [Abstract][Full Text] [Related]
43. Could prostate biopsies be avoided in men older than 75 years with raised PSA?
Nomikos M; Mariappan P; Zachou A; McNeill A; Bollina PR
Urol Int; 2010; 85(4):410-4. PubMed ID: 20962505
[TBL] [Abstract][Full Text] [Related]
44. Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making.
Nnabugwu II; Ugwumba FO; Enivwenae OA; Udeh EI; Otene CO; Nnabugwu CA
Clin Interv Aging; 2015; 10():89-93. PubMed ID: 25565791
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
[TBL] [Abstract][Full Text] [Related]
46. Defining prostate cancer risk before prostate biopsy.
Pal RP; Maitra NU; Mellon JK; Khan MA
Urol Oncol; 2013 Nov; 31(8):1408-18. PubMed ID: 22795499
[TBL] [Abstract][Full Text] [Related]
47. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
[TBL] [Abstract][Full Text] [Related]
48. Frequency of residual neoplasm in the prostate following three-dimensional conformal radiotherapy.
Forman JD; Oppenheim T; Liu H; Montie J; McLaughlin PW; Porter AT
Prostate; 1993; 23(3):235-43. PubMed ID: 7694267
[TBL] [Abstract][Full Text] [Related]
49. [A rare case of primitive prostatic large B-cell lymphoma and review of literature].
Chargari C; Gillion N; Ghalibafian M; Ribrag V; Girinsky T; Magné N
Cancer Radiother; 2009 Jan; 13(1):69-71. PubMed ID: 19101192
[TBL] [Abstract][Full Text] [Related]
50. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
[TBL] [Abstract][Full Text] [Related]
51. Primary pancreatic lymphoma: report of six cases.
Lin H; Li SD; Hu XG; Li ZS
World J Gastroenterol; 2006 Aug; 12(31):5064-7. PubMed ID: 16937508
[TBL] [Abstract][Full Text] [Related]
52. Can free and total prostate specific antigen and prostatic volume distinguish between men with negative and positive systematic ultrasound guided prostate biopsies?
Prestigiacomo AF; Stamey TA
J Urol; 1997 Jan; 157(1):189-94. PubMed ID: 8976248
[TBL] [Abstract][Full Text] [Related]
53. Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer.
Beard CJ; Chen MH; Cote K; Loffredo M; Renshaw AA; Hurwitz M; D'Amico AV
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):19-24. PubMed ID: 14697416
[TBL] [Abstract][Full Text] [Related]
54. Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy?
Durkan GC; Greene DR
BJU Int; 1999 Jan; 83(1):34-8. PubMed ID: 10233448
[TBL] [Abstract][Full Text] [Related]
55. [A CASE OF PROSTATE CANCER WITH UNUSUAL PATTERN OF RECURRENCE AFTER RADIOTHERAPY].
Oshinomi K; Fukagai T; Ogawa Y; Sato N; Morita J; Aso T; Igarashi A; Morita M; Naoe M; Fuji K; Ogawa Y
Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):40-4. PubMed ID: 26399130
[TBL] [Abstract][Full Text] [Related]
56. Detection rate of prostate cancer using prostate specific antigen in patients presenting with lower urinary tract symptoms: a retrospective study.
Chavan PR; Chavan SV; Chavan NR; Trivedi VD
J Postgrad Med; 2009; 55(1):17-21. PubMed ID: 19242073
[TBL] [Abstract][Full Text] [Related]
57. [PSA volume quotient: an additional parameter in diagnosis of locally confined prostate cancer].
Gottfried HW; Kleinschmidt K; Flohr P; Miller K; Hautmann R
Urologe A; 1993 Nov; 32(6):455-9. PubMed ID: 7506850
[TBL] [Abstract][Full Text] [Related]
58. [The usefulness of percentage of free prostate specific antigen/prostate specific antigen density in the diagnosis of prostate cancer].
Han G; Gao JP; Cao XL; Hong BF; Tang J
Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):379-81. PubMed ID: 16638346
[TBL] [Abstract][Full Text] [Related]
59. [Systematic ultrasound guided transrectal core prostate biopsy based on serum level of prostate-specific antigen].
Yamaguchi S; Baba Y; Naito K
Hinyokika Kiyo; 1997 Sep; 43(9):641-5. PubMed ID: 9365843
[TBL] [Abstract][Full Text] [Related]
60. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
